• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者外周血B淋巴细胞的表型改变。

Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease.

作者信息

Wang Meng-Ting, Wang Ye-Ran, Zeng Gui-Hua, Zeng Xiao-Qin, Fei Zhang-Cheng, Chen Jia, Zhou Jin, Li Xin-Peng, Xu Zhi-Qiang, Wang Yan-Jiang, Liu Yu-Hui

机构信息

Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, PR China.

Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China. Postal address: 400010.

出版信息

J Prev Alzheimers Dis. 2025 Aug;12(7):100135. doi: 10.1016/j.tjpad.2025.100135. Epub 2025 Mar 21.

DOI:10.1016/j.tjpad.2025.100135
PMID:40121165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12321623/
Abstract

INTRODUCTION

Dysfunction of humoral immunity has been implicated in the pathogenesis of Alzheimer's disease (AD). The distribution of B lymphocyte subsets and their clinical relevance in AD remain unclear.

OBJECTIVE

In this study, we aimed to investigate the distribution of peripheral blood B lymphocyte subsets and their relevance with cognition and biomarkers in AD.

DESIGN, SETTING, AND PARTICIPANTS: We evaluated the immunophenotype of peripheral B lymphocytes in 27 AD patients confirmed by PET-Amyloid scan and 32 cognitively normal controls.

RESULTS

The phenotype of B lymphocytes is altered in AD patients. AD patients exhibit a decrease in both the numbers and proportions of switched memory (SwM) B cells and double-negative (DN) B cells. The proportion of unswitched memory (USwM) B cells was increased after in vitro stimulation. Additionally, B cells that produce proinflammatory cytokines including GM-CSF, IFN-γ, and TNF-α are increased, while those that produce the anti-inflammatory cytokine IL-10 are decreased in AD patients after in vitro stimulation. These alterations in B cell populations were linked to cognitive functions and biomarkers, including Aβ42/40 and pTau181, in AD patients.

DISCUSSION

This study reveals an altered B-lymphocyte phenotype in AD patients, marked by functional and compositional dysregulation. Further research incorporating mechanistic, longitudinal, and functional studies is needed to determine whether these immune perturbations directly contribute to AD pathogenesis or arise as secondary effects of neurodegeneration.

摘要

引言

体液免疫功能障碍与阿尔茨海默病(AD)的发病机制有关。AD中B淋巴细胞亚群的分布及其临床相关性尚不清楚。

目的

在本研究中,我们旨在调查外周血B淋巴细胞亚群的分布及其与AD认知和生物标志物的相关性。

设计、设置和参与者:我们评估了27例经PET淀粉样蛋白扫描确诊的AD患者和32例认知正常对照者外周B淋巴细胞的免疫表型。

结果

AD患者B淋巴细胞的表型发生改变。AD患者转换记忆(SwM)B细胞和双阴性(DN)B细胞的数量和比例均降低。体外刺激后未转换记忆(USwM)B细胞的比例增加。此外,体外刺激后,AD患者中产生促炎细胞因子(包括GM-CSF、IFN-γ和TNF-α)的B细胞增加,而产生抗炎细胞因子IL-10的B细胞减少。AD患者B细胞群体的这些改变与认知功能和生物标志物有关,包括Aβ42/40和pTau181。

讨论

本研究揭示了AD患者B淋巴细胞表型的改变,其特征是功能和组成失调。需要进一步开展机制、纵向和功能研究,以确定这些免疫紊乱是直接导致AD发病机制还是作为神经退行性变的继发效应出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/2287514078a1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/57eedbcf4bc2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/2219d9c66b66/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/fb99a10ea42f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/51e1d46c4fe6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/69e91a7cd0bc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/2287514078a1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/57eedbcf4bc2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/2219d9c66b66/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/fb99a10ea42f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/51e1d46c4fe6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/69e91a7cd0bc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f45/12321623/2287514078a1/gr6.jpg

相似文献

1
Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease.阿尔茨海默病患者外周血B淋巴细胞的表型改变。
J Prev Alzheimers Dis. 2025 Aug;12(7):100135. doi: 10.1016/j.tjpad.2025.100135. Epub 2025 Mar 21.
2
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
5
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion.与阿尔茨海默病表型及轻度认知障碍向阿尔茨海默病转化相关的不同脑脊液α-突触核蛋白聚集谱。
J Prev Alzheimers Dis. 2025 Feb;12(2):100040. doi: 10.1016/j.tjpad.2024.100040. Epub 2025 Jan 3.
6
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis.在检测脑淀粉样变性方面,血浆pTau217与Aβ42的比值比单独测量更具优势。
medRxiv. 2025 Jan 10:2024.12.07.24318640. doi: 10.1101/2024.12.07.24318640.
7
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
8
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.
9
Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics.理清三级记忆诊所患者中阿尔茨海默病血浆生物标志物与既定生物标志物之间的关系。
EBioMedicine. 2025 Feb;112:105504. doi: 10.1016/j.ebiom.2024.105504. Epub 2024 Dec 18.
10
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease.数据驱动的脑脊液生物标志物分析:阿尔茨海默病风险队列中的影像学和临床结果
Alzheimers Res Ther. 2024 Dec 23;16(1):274. doi: 10.1186/s13195-024-01629-y.

引用本文的文献

1
MiRNA-501-3p and MiRNA-502-3p: A promising biomarker panel for Alzheimer's disease.微小RNA-501-3p和微小RNA-502-3p:一种有前景的阿尔茨海默病生物标志物组合
Clin Transl Med. 2025 Jul;15(7):e70389. doi: 10.1002/ctm2.70389.

本文引用的文献

1
Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer's disease.针对 BACE1 的自身抗体促进阿尔茨海默病中 Aβ 的积累和神经退行性变。
Acta Neuropathol. 2024 Oct 24;148(1):57. doi: 10.1007/s00401-024-02814-x.
2
IL-10 regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.IL-10 调节性 B 细胞通过抑制嗜酸性粒细胞活化来减轻特应性皮炎。
Sci Rep. 2024 Aug 6;14(1):18164. doi: 10.1038/s41598-024-68660-9.
3
Peripheral Immune Cells Contribute to the Pathogenesis of Alzheimer's Disease.外周免疫细胞促成阿尔茨海默病的发病机制。
Mol Neurobiol. 2025 Jan;62(1):264-270. doi: 10.1007/s12035-024-04266-6. Epub 2024 Jun 6.
4
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
5
Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease.帕金森病患者外周血 B 淋巴细胞免疫功能异常。
Parkinsonism Relat Disord. 2023 Nov;116:105890. doi: 10.1016/j.parkreldis.2023.105890. Epub 2023 Oct 11.
6
Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis.超越淀粉样蛋白假说:当前研究如何提示自身免疫在阿尔茨海默病发病机制中的作用。
Crit Rev Clin Lab Sci. 2023 Sep;60(6):398-426. doi: 10.1080/10408363.2023.2187342. Epub 2023 Mar 20.
7
Pathogenesis of Alzheimer's Disease.阿尔茨海默病的发病机制。
Int J Mol Sci. 2022 Dec 21;24(1):107. doi: 10.3390/ijms24010107.
8
Associations of Naturally Occurring Antibodies to Presenilin-1 with Brain Amyloid-β Load and Cognitive Impairment in Alzheimer's Disease.阿尔茨海默病中针对早老素-1的天然抗体与脑淀粉样β蛋白负荷及认知障碍的关联
J Alzheimers Dis. 2022;90(4):1493-1500. doi: 10.3233/JAD-220775.
9
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease.B 细胞特征和受体库与阿尔茨海默病进展的关联。
Cell Rep. 2022 Sep 20;40(12):111391. doi: 10.1016/j.celrep.2022.111391.
10
Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.基于与阿尔茨海默病中小胶质细胞相关的“组学”分析的发病机制、治疗策略和生物标志物的开发。
J Neuroinflammation. 2022 Sep 4;19(1):215. doi: 10.1186/s12974-022-02580-1.